stars 1 stars 2 stars 3

MABLife is a private biotech company founded in 1999, specialising in the development of antibody-based therapeutics for the treatment of cancer, ophthalmic diseases, autoimmune & inflammatory disorders and nosocomial infections. The Company has a focused portfolio of products in development, including one product currently in phase I/II and four at different stages of preclinical development.

MABLife Questions

The MABLife annual revenue was $3.2 million in 2026.

1 people are employed at MABLife.

MABLife is based in Evry, Ile-de-France.

The NAICS codes for MABLife are [325, 32, 3254].

The SIC codes for MABLife are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users